CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: A study by the Groupe d'Etude des Lymphomes de l'Adulte

Journal of Clinical Oncology

Volumn 25, Issue 7, 2007, Pages 787-792

  Bonnet, Christophe ^a   Fillet, Georges ^a   Mounier, Nicolas ^a   Ganem, Gérard ^a   Molina, Thierry Jo ^a   Thiéblemont, Catherine ^a   Fermé, Christophe ^a   Quesnel, Bruno ^a   Martin, Claude ^a   Gisselbrecht, Christian ^a   Tilly, Hervé ^a   Reyes, Félix ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CHOP PROTOCOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; ADJUVANT THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PREDNISONE; RADIOTHERAPY, ADJUVANT; VINCRISTINE;

EID: 33947543250     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.0722     Document Type: Article

References (23)

1. Chen MG, Prosnitz LR, Gonzalez-Serva A, et al: Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 43:1245-1254, 1979
2. Connors JM, Klimo P, Fairey RN, et al: Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 107:25-30, 1987
3. Cabanillas F, Bodey GP, Freireich EJ: Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer 46:2356-2359, 1980
4. Jones SE, Miller TP, Connors JM: Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy. J Clin Oncol 7:1186-1191, 1989
5. Miller TP, Dahlberg S, Cassady JR, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339:21-26, 1998
6. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
7. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
8. Stansfeld AG, Diebold J, Noel H, et al: Updated Kiel classification for lymphomas. Lancet 1:292-294, 1988
9. Jaffe ES, Harris NL, Stein H, et al: World Health Organization Classification of Tumours/ Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, International Agency for Research on Cancer, 2001
10. Cheson BD, Horning SJ, Coiffier B, et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas: NCI-sponsored international working group. J Clin Oncol 17:1244-1253, 1999
11. Kaplan E, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
13. Cox D: Regression model and life tables. J R Stat Soc B 34:187-220, 1972
14. Shenkier TN, Voss N, Fairey R, et al: Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: An 18-year experience from the British Columbia Cancer Agency. J Clin Oncol 20:197-204, 2002
15. Zinzani PL, Martelli M, Magagnoli M, et al: Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood 94:3289-3293, 1999
16. Connors J: Principles of chemotherapy and combined modality therapy, in Mauch P, Armitage J, Coiffier B, et al (eds): Non-Hodgkin's Lymphomas. Philadelphia, PA, Lippincott Williams & Wilkins, 2004, pp 201-219
17. Miller TP, Leblanc M, Spier CM, et al: CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: Update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98:S742-S743, 2001 (suppl)
18. Horning SJ, Weller E, Kim K, et al: Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group Study 1484. J Clin Oncol 22:3032-3038, 2004
19. Miller TP: The limits of limited stage lymphoma. J Clin Oncol 22:2982-2984, 2004
20. Armitage JO, Carbone PP, Connors JM, et al: Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. J Clin Oncol 21:897-906, 2003
21. Reyes F, Lepage E, Ganem G, et al: ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 352:1197-1205, 2005
22. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
23. Feugier P, Van Hoof A, Sebban C, et al: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23:4117-4126, 2005